FAST NEWS: Clover Bio slumps after booting from China-Hong Kong Stock Connect
The latest: The Shanghai and Shenzhen stock exchanges removed Clover Biopharmaceuticals Ltd. (2197.HK) from their list of securities eligible for trading in the Hong Kong-China Stock Connect program, as part of…
Falling IPO Star: Hong Kong Tipped to Lose Top-Three Ranking Again
Hong Kong is losing some of its luster as an IPO hub, hit by market worries about soaring inflation, rising interest rates, tumbling stock prices and China’s zero-Covid policy. Some…
RELATED ARTICLES
-
Dispute over Covid vaccines casts doubt on Clover Bio recovery
2197.HK - Despite government efforts, China-Europe stock connects fail to take flight
- Pateo Connect revs up for IPO, belching widening losses and slumping margins
-
Café de Coral slumps as dark clouds hover over restaurant industry
0341.HK
-
Tsui Wah goes to college as consumers dine out less
1314.HK
-
Seyond may get stuck in slow-moving SPAC lane to Hong Kong listing
7855.HK
-
Last orders: leading rice noodle chain to delist from Hong Kong
2217.HK
